• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Development of the treatment for fulminant type1 diabetes using the model mouse

Research Project

  • PDF
Project/Area Number 21591149
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionOsaka Medical College

Principal Investigator

HANAFUSA Toshiaki  大阪医科大学, 医学部, 教授 (60164886)

Co-Investigator(Kenkyū-buntansha) SANO Hiroyuki  大阪医科大学, 医学部, 助教 (20556435)
Project Period (FY) 2009 – 2011
Keywords劇症1型糖尿病 / encephalomyocarditis virus / GLP-1 / マクロファージ
Research Abstract

This study has shown that exendin-4 suppresses the onset of encephalomyocarditis virus(EMCV) induced diabetes, which is a model of fulminant type 1 diabetes. Exendin-4 markedly reducedβ cell destruction by inhibiting the infiltration of macrophages into the islets and the expression of EMCV infected macrophage derived chemical mediators, TNF-α, IL-1β and iNOS. Our study clarified that it could be an important strategy to suppress macrophage activation in the treatment of fulminant type1 diabetes.

  • Research Products

    (8 results)

All 2012 2011 2010 2009

All Journal Article (4 results) (of which Peer Reviewed: 2 results) Presentation (3 results) Book (1 results)

  • [Journal Article] Low CTLA-4 expression in CD4+helper T-cells in patients with fulminant type 1 diabetes2011

    • Author(s)
      Haseda F, Imagawa A, Murase-Mishiba Y, Sano H, Hirano-Kuwata S, Ueda H, Terasaki J, Hanafusa T.
    • Journal Title

      Immunol Lett

      Volume: 30 Pages: 139(1-2): 80-6

    • Peer Reviewed
  • [Journal Article] Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreaticβ-cell destruction induced by encephalomyocarditis virus.2010

    • Author(s)
      Sano H, Terasaki J, Mishiba Y, Imagawa A, Hanafusa T.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 21 Pages: 404(3): 756-61

    • Peer Reviewed
  • [Journal Article] 特集:インクレチン製剤-基礎と臨床「膵島移植の際にインクレチン製剤は?」2010

    • Author(s)
      佐野寛行・花房俊昭
    • Journal Title

      肥満と糖尿病

      Volume: Vol09-No.4 Pages: 575-579

  • [Journal Article] 1型糖尿病になるのはなぜか(原因・機序)2009

    • Author(s)
      佐野寛行花房俊昭
    • Journal Title

      糖尿病のすべて

      Pages: 24-28

  • [Presentation] Exendin-4はEMCウイルスによる膵β細胞破壊を抑制する2011

    • Author(s)
      佐野寛行、寺前純吾、長谷田文孝、堤千春、大西峰樹、三柴裕子、今川彰久、花房俊昭
    • Organizer
      第54回日本糖尿病学会年次学術集会
    • Place of Presentation
      札幌
    • Year and Date
      20110519-21
  • [Presentation] 脳心筋炎(EMC)ウイルスによって誘導される膵β細胞破壊に対するexendin-4の効果2011

    • Author(s)
      佐野寛行
    • Organizer
      糖尿病治療UP TO DATE
    • Place of Presentation
      大阪
    • Year and Date
      2011-11-25
  • [Presentation] 新時代の糖尿病治療2011

    • Author(s)
      佐野寛行
    • Organizer
      第268回臨床心臓病研修会
    • Place of Presentation
      大阪
    • Year and Date
      2011-11-19
  • [Book] 1型糖尿病における膵β細胞障害の分子機構2012

    • Author(s)
      長谷田文孝, 佐野寛行, 寺前純吾, 花房俊昭
    • Total Pages
      52-62
    • Publisher
      羊土社

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi